anagrelide


anagrelide

 [an-ag´rĕ-līd] an agent used in the form of the hydrochloride salt to reduce elevated platelet counts and the risk of thrombosis in treatment of thrombocythemia" >hemorrhagic thrombocythemia; administered orally.

anagrelide

A cytoreductive agent used to manage essential thrombocythaemia and thrombocythaemia due to myeloproliferative disorders (e.g., CML, polycythemia vera) to reduce platelets, risk of thrombosis and other symptoms. It is generally regarded as a second-line therapy compared to hydroxyurea.

Anagrelide

An orphan drug that is approved for treating PV patients on an investigational basis. Anagrelide works by controlling the level of platelets in the blood.Mentioned in: Polycythemia Vera